Vir biotechnology to participate in td cowen 6th annual oncology innovation summit

San francisco--(business wire)--vir biotechnology, inc. (nasdaq: vir), today announced that marianne de backer, m.sc., ph.d., mba, chief executive officer, and mika kakefuda derynck, m.d., executive vice president, therapeutic area head, oncology, will participate in a virtual fireside chat at the td cowen 6th annual oncology innovation summit on tuesday, may 27 at 1:30 p.m. pt / 4:30 p.m. et. a live webcast of the fireside chat will be made available under events & presentations in the inv.
COWN Ratings Summary
COWN Quant Ranking